(Q98681721)

English

A phase III study to investigate a vaccine against COVID-19

No description defined

In more languages
default values for all languages
No label defined

No description defined

Statements

A phase III randomized controlled trial to determine safety, efficacy, and immunogenicity of the non-replicating ChAdOx1 nCoV-19 vaccine (English)
0 references
0 references
Peter O'Reilly
0 references
1 May 2020
0 references
31 October 2021
0 references
11 June 2020
0 references
2,000
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit